These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37396757)

  • 1. Time to achieve a patient acceptable symptom state in myasthenia gravis.
    Martinez-Harms R; Barnett C; Bril V
    Front Neurol; 2023; 14():1187189. PubMed ID: 37396757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the single simple question and the patient acceptable symptom state in myasthenia gravis.
    Menon D; Barnett C; Bril V
    Eur J Neurol; 2020 Nov; 27(11):2286-2291. PubMed ID: 32537828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis index.
    Menon D; Alnajjar S; Barnett C; Vijayan J; Katzberg H; Fathi D; Alcantara M; Bril V
    Muscle Nerve; 2021 Jun; 63(6):831-836. PubMed ID: 33792967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-acceptable symptom states in myasthenia gravis.
    Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C
    Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis.
    Vijayan J; Menon D; Barnett C; Katzberg H; Lovblom LE; Bril V
    Muscle Nerve; 2021 Oct; 64(4):462-466. PubMed ID: 34235762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis.
    Urra Pincheira A; Alnajjar S; Katzberg H; Barnett C; Daniyal L; Rohan R; Bril V
    Muscle Nerve; 2022 Nov; 66(5):558-561. PubMed ID: 35673960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoma pathology and myasthenia gravis outcomes.
    Menon D; Katzberg H; Barnett C; Pal P; Bezjak A; Keshavjee S; Bril V
    Muscle Nerve; 2021 Jun; 63(6):868-873. PubMed ID: 33675078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis.
    Andersen LK; Jakobsson AS; Revsbech KL; Vissing J
    J Neurol; 2022 Jun; 269(6):3086-3093. PubMed ID: 34806129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.
    Barnett C; Bril V; Kapral M; Kulkarni AV; Davis AM
    Neurology; 2017 Dec; 89(23):2357-2364. PubMed ID: 29101274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Patient Sociodemographic Factors Impact the PROMIS Scores Meeting the Patient-Acceptable Symptom State at the Initial Point of Care in Orthopaedic Foot and Ankle Patients?
    Bernstein DN; Mayo K; Baumhauer JF; Dasilva C; Fear K; Houck JR
    Clin Orthop Relat Res; 2019 Nov; 477(11):2555-2565. PubMed ID: 31261259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.
    Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
    JAMA Neurol; 2020 Aug; 77(8):974-981. PubMed ID: 32364568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
    de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.
    Dougados M; Luo MP; Maksymowych WP; Chmiel JJ; Chen N; Wong RL; Davis JC; van der Heijde D;
    Arthritis Rheum; 2008 Apr; 59(4):553-60. PubMed ID: 18383418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
    Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
    Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.